These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

766 related articles for article (PubMed ID: 29441009)

  • 21. The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.
    Liu Z; Li T; Li P; Wei N; Zhao Z; Liang H; Ji X; Chen W; Xue M; Wei J
    Oxid Med Cell Longev; 2015; 2015():352723. PubMed ID: 26171115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: tangle formation, amyloid-β, and microglia in Alzheimer's disease.
    Takata K; Kitamura Y
    J Pharmacol Sci; 2012; 118(3):331-7. PubMed ID: 22382659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus.
    Zhang ZX; Zhao RP; Wang DS; Li YB
    Neurochem Res; 2016 Nov; 41(11):3074-3082. PubMed ID: 27518086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selenium-enriched yeast inhibited β-amyloid production and modulated autophagy in a triple transgenic mouse model of Alzheimer's disease.
    Song GL; Chen C; Wu QY; Zhang ZH; Zheng R; Chen Y; Jia SZ; Ni JZ
    Metallomics; 2018 Aug; 10(8):1107-1115. PubMed ID: 30043821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid-beta aggregation implicates multiple pathways in Alzheimer's disease: Understanding the mechanisms.
    Iliyasu MO; Musa SA; Oladele SB; Iliya AI
    Front Neurosci; 2023; 17():1081938. PubMed ID: 37113145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps].
    Kuzuhara S
    Brain Nerve; 2010 Jul; 62(7):659-66. PubMed ID: 20675870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beyond the classical amyloid hypothesis in Alzheimer's disease: Molecular insights into current concepts of pathogenesis, therapeutic targets, and study models.
    Theerasri A; Janpaijit S; Tencomnao T; Prasansuklab A
    WIREs Mech Dis; 2023 Mar; 15(2):e1591. PubMed ID: 36494193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
    Watanabe H
    Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
    Maccioni RB; Muñoz JP; Barbeito L
    Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer's Disease.
    Mroczko B; Groblewska M; Litman-Zawadzka A; Kornhuber J; Lewczuk P
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of cdk5 in the pathogenesis of Alzheimer's disease.
    Lau LF; Ahlijanian MK
    Neurosignals; 2003; 12(4-5):209-14. PubMed ID: 14673207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
    Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
    J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of tau phosphorylation in Alzheimer's disease.
    Lee VM
    Ann N Y Acad Sci; 1996 Jan; 777():107-13. PubMed ID: 8624072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer's disease.
    Zhang Y; Chen X; Zhao Y; Ponnusamy M; Liu Y
    Rev Neurosci; 2017 Nov; 28(8):861-868. PubMed ID: 28704199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metal ions influx is a double edged sword for the pathogenesis of Alzheimer's disease.
    Wang P; Wang ZY
    Ageing Res Rev; 2017 May; 35():265-290. PubMed ID: 27829171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?
    Castillo-Carranza DL; Guerrero-Muñoz MJ; Kayed R
    Immunotargets Ther; 2014; 3():19-28. PubMed ID: 27471697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perspective Insights into Disease Progression, Diagnostics, and Therapeutic Approaches in Alzheimer's Disease: A Judicious Update.
    Jan AT; Azam M; Rahman S; Almigeiti AMS; Choi DH; Lee EJ; Haq QMR; Choi I
    Front Aging Neurosci; 2017; 9():356. PubMed ID: 29163138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpesviral infections and antimicrobial protection for Alzheimer's disease: Implications for prevention and treatment.
    Qin Q; Li Y
    J Med Virol; 2019 Aug; 91(8):1368-1377. PubMed ID: 30997676
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.